Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates
Golden, Colorado & Nashville, Tennessee, Dec. 18, 2023 -- Theralink Technologies , a precision oncology company with an exclusively licensed commercial RPPA technology platform, is excited to...
United States San Francisco Trevor Mccartney Emanuelf Petricoin Globenewswire Inc University Professor
Source: marketscreener.com